title: Better Outcomes with Precision Medicine.
abstract: Final results from MOSCATO-01, a prospective precision medicine-based trial, indicate that molecular profiling improves outcomes for patients with diverse types of advanced cancer. Compared with previous nontargeted therapy, progression-free survival was extended by 30% in a third of patients whose treatment was tailored to their tumor's genetic makeup.
mesh_terms: D002986:Clinical Trials as Topic; D055028:Comparative Genomic Hybridization; D023281:Genomics / Q000379:methods*; D006801:Humans; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D057285:Precision Medicine / Q000379:methods*; D011379:Prognosis; D017422:Sequence Analysis, DNA; D017423:Sequence Analysis, RNA; D016019:Survival Analysis; D016896:Treatment Outcome